|

Paclitaxel+Carboplatin Clinical Trials

2 actively recruiting trials

Also known as: Paclitaxel group, Wee1 inhibitor+ PARAPLATIN+Taxol

Pipeline

Phase 3: 1Phase 1/2: 1

Top Sponsors

  • Wigen Biomedicine Technology (Shanghai) Co., Ltd.1
  • Shengjing Hospital1

Indications

  • Cancer2
  • Advanced Solid Tumor1
  • Breast Cancer1

Other2 trials

A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors
Phase 1/2
Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.